Recombinant Proteins Market worth $1 7 billion by 2026 - Size, Industry Trends, Key Players and Forecast sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
The cells of simple organisms, such as bacteria, as well as human cells are surrounded by a membrane, which fulfills various tasks including protecting the cell from stress.
Membrane Proteins of Bacteria and Humans Show Surprising Similarities miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Posted April 14th, 2021 for Datalogic
The compactness of a smart camera with the power of a vision system
Bologna , April 14
th , 2021. Datalogic, a global leader in the automatic data capture and factory automation markets, is pleased to announce the P2X series, the ultimate smart camera with the unparalleled performance and flexibility of the most innovative vision system. Although very technically capable, the P2X is easily setup and operated. The heavyweight specifications packed into the industrial-grade camera housing will let operators tackle the most demanding of application requirements. The small form factor and large field of view make it the ideal camera on robot guidance applications. The powerful and feature-rich built-in lighting system is designed to be used on production lines for materials of all shapes, sizes and colors. The benefits are endless, and it is undeniable that the new P2X series from Datalogic is a far superior smart camera to all othe
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global recombinant proteins market is projected to reach USD 1.7 billion by 2026 from USD 1 billion in 2021, at a CAGR of 9.8% during the forecast period.
The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry academia collaborations, and the patent expiry of biologic products.
Emerging markets in Asian countries and the rising focus on personalized medicine & protein therapeutics are other factors expected to offer strong growth opportunities for players in the recombinant proteins market. In contrast, the declining cost of recombinant proteins may restrict market growth to a certain extent.